跳至主要内容
临床试验/CTRI/2024/04/065250
CTRI/2024/04/065250已完成4 期

An Open-label, Prospective, Randomized, Multi-Center, Clinical Trial Designed to Evaluate the Clinical Outcomes with Digital Workflow Solution Versus Conventional Workflow Solution Refractive Outcomes Among Patients Undergoing Cataract Surgery with Toric Intraocular Lens

Center for Application Research in India (CARIn) Carl Zeiss India2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年4月11日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
One-month postoperative refraction

研究概览

简要总结

An Open-label, Prospective, Randomized, Multi-Center, Clinical Trial Designed to Evaluate the Clinical Outcomes with Digital Workflow Solution Versus Conventional Workflow Solution Refractive Outcomes Among Patients Undergoing Cataract Surgery with Toric Intraocular Lens, Sponsor name-Center for Application Research in India (CARIn) Carl Zeiss India (Bangalore) Pvt Ltd Bangalore, India. Sample size is 80 subjects of which 40 subjects will receive Digital Workflow Solution and rest 40 subjects will receive Conventional Workflow Solution, Where the primary end point is Primary endpoints: One-month postoperative manifest refraction. Secondary Endpoints: Uncorrected and best-corrected visual acuity by log MAR visual acuity: 1 month, IOL axis alignment: immediate postop; 1-day postop, and 1 month postop.

The Exploratory Endpoints: Time to manually mark IOL axis prior to surgery by the surgeon, before drops used (patient prep time, # drops, time for axis marking at slit lamp, patient transport to OR), Total surgery time for cataract extraction and Toric IOL implantation, Time for IOL alignment during surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Subjects with regular corneal astigmatism greater than 0.75D willing to undergo cataract extraction.
  • Patient willing to undergo cataract surgery with implantation of an Toric intraocular lenses.
  • Patient giving full and free consent for involvement in the study.
  • Patient willing to come for follow up study visits and measurements.

排除标准

  • Any ocular pathology or degeneration that could have impact on vision and/or a contradiction to Toric IOL implantation.
  • Any surgical complication felt to in any way impact upon the quality of visual outcome.
  • Any other comorbid conditions or risk factors that may affect the surgical procedure.

结局指标

主要结局

One-month postoperative refraction

时间窗: 1 week and 1 month

次要结局

  • Uncorrected & best corrected visual acuity by log MAR visual acuity 1 month. IOL axis alignment, immediate postop, 1 day postop & 1 month postop.(1 week & 1 month.)

研究者

发起方
Center for Application Research in India (CARIn) Carl Zeiss India
申办方类型
Other [Medical Technology Company]
责任方
Principal Investigator
主要研究者

Dr Merle Fernandes

LV Prasad Eye Institute

研究点 (2)

Loading locations...

相似试验